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Abstract
The composition and function of human milk is unique and gives a basis for the development of modern artificial
milk formulas that can provide an appropriate substitute for non-breastfed infants. Although human milk is not fully
substitutable, modern milk formulas are attempting to mimic human milk and partially substitute its complex
biological positive effects on infants. Besides the immunomodulatory factors from human milk, research has been
focused on the composition and structure of human milk fat with a high content of β-palmitic acid (sn-2 palmitic
acid, β-palmitate). According to the available studies, increasing the content of β-palmitate added to milk formulas
promotes several beneficial physiological functions. β-palmitate positively influences fatty acid metabolism, increases
calcium absorption, improves bone matrix quality and the stool consistency, and has a positive effect on the
development of the intestinal microbiome.
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Introduction
Human milk represents the optimal nutrition for a baby
after birth and during the whole nursing period. Progres-
sive discoveries of its particular components together with
determining their physiological functions has allowed
better understanding of this unique liquid. Besides nutri-
tional functions, we can distinguish a whole spectrum of
functions in human milk, including immunomodulatory
and other physiological activities. Revealing the function
and importance of particular components has allowed for
improvement of modern supplemental milk formulas for
infants who, for various reasons, cannot be breastfed.
Modern preparations of supplemental milk nutrition try
to copy and imitate the components of human milk to
achieve not only its nutritional properties, but also other
physiological functions that are provided by human milk
to a breastfed child [1].
Review
Physiology of milk fat
The energy requirements of a baby are high. An important
component of human milk, as in milk formulas, is fat,
which presents an important source of energy (approxi-
mately 50 % of the energetic content of human milk and
formulas). Up to 98 % of human milk lipids is in the form
of triacylglycerols, in which saturated and non-saturated
fatty acids are bound to the skeleton of glycerol. Palmitic
acid, the major saturated fatty acid in human milk, usually
represents about 20–25 % of human milk fatty acids. Sixty
percent (according to some authors, up to about 86 %) of
palmitic acid is esterified to the sn-2 position in the triac-
ylglycerols (the so-called β-position) [2–4]. The shortened
name for palmitic acid bound to glycerol in the β-position
(sn-2) is β-palmitate. However, in the majority of supple-
mental milk formulas, with vegetable oils as commonly
used source of fat, have palmitic acid bound to the 1st or
3rd carbon of glycerol (sn-1 and −3 positions). [4]. Cow’s
milk, as well as plant fats, have lower content of β-
palmitate compared to human milk (cow’s milk only about
40 %, plant oils even only 5–20 %) [5]. Besides saturated
fatty acids, milk also contains polyunsaturated fatty acids
with a long chain, as well as essential fatty acids (linoleic
acid and α-linoleic). The balanced content of these fatty
acids is necessary for the correct maturation of the
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nervous system and for visual perception, as well as for-
mation of important biologic mediators, e.g. eicosanoids
[6, 7].
The importance of the sn-2 bond is in the regulation
of digestion and subsequent fat absorption. The first en-
zyme that digests fats is gastric lipase, which is already
well developed in newborns. Subsequently, pancreatic
lipase continues fat digestion in the gut, but a certain
immaturity of the exocrine function of the pancreas is
observed in neonates. Bile-salt stimulated lipase from
human milk has an important role in breastfed infants.
Gastric lipase accounts for approximately 10 % and
lipase stimulated by biliary salts accounts for 20–40 % of
fat digestion [8]. Pancreatic lipase separates fatty acids in
the sn-1 and sn-3 positions, while the middle position is
relatively resistant to lytic activity of this enzyme [9].
When the activity of pancreatic lipase in the intestine is
appropriate, the final result of digestion of fats is free
fatty acids and 2-monoacylglycerol, which subsequently
creates micelles with biliary acids and is absorbed
quickly. However, free saturated fatty acids with a long
chain (e.g. palmitic acid), and a sufficient amount of cal-
cium in the intestinal lumen, create non-soluble calcium
soaps and so lower the overall availability of calcium for
the child. If palmitic acid is bound in the sn-2 position
to glycerol, it does not create compounds with calcium,
but is absorbed [5, 10]. If infants are fed with fats contain-
ing mainly palmitic acid located in the sn-1 and sn-3
position, the insufficient pancreatic lipase activity in-
creases the risk of forming poorly absorbed calcium soaps.
This is the reason why, according to the pattern of
human milk, a high content of palmitic acid in the sn-2
position in milk formula leads to higher absorption and
efficiency of palmitic acid in comparison with supple-
mental milk formulas with triacylglycerols derived from
vegetable oils that are predominantly in the sn-1 and sn-
3 position [11]. Several studies have revealed that fat
from human milk is better absorbed than fat from supple-
mental milk formulas, while increasing the β-palmitate in
formulas aims to achieve the level of fat absorption from
formulas at that from human milk. The content of fatty
acids bound in the β-position to glycerol is distinctly
different in various supplemental milk formulas [3]. Fur-
thermore, when analysing various supplementary milk
formulas, there were significant differences in the stereo-
specific structure of fatty acids, as well as in the profile of
particular fatty acids in comparison with human milk [4].
Regarding palmitic acid, although differences were not
that great in its content, there were differences in the pro-
portion of its binding in the sn-2 position. Similarly, the
content of fatty acids in human milk changes depending
on the mother’s diet [12]. The gradual identification of
particular components of human milk, as well as deter-
mination of their physiological importance, has led to
adjustments of supplemental milk formulas with the aim
of providing for infants who cannot be breastfed, for
various reasons, similar benefits as those of human milk.
Besides adjustment of the content of particular immuno-
modulatory (nucleotides, prebiotics, oligosaccharides, pro-
biotics, vitamins) and other essential components with
metabolic and other physiological functions (polyun-
saturated fatty acids, carnitine, choline, taurine, minerals,
vitamins) attention is increasingly turning towards the
fatty components of cow’s milk [1].
Under physiological conditions, palmitic acid is an im-
portant component of human milk. On the basis of
available analyses, an important part of palmitic acid is
bound to the skeleton of glycerol in triacylglycerols in
the sn-2 position (position β), which has important
physiological and metabolic implications in breastfed
infants in comparison with infants fed supplemental
milk formula [13].
In addition, changes in the position of palmitate on
the molecule of glycerol may influence the presentation
of fats in the plasma and their metabolism [14, 15].
However, some authors have suggested that differences
in the physical characteristics of fats resulting from
inter-esterification and changes in triacylglycerol struc-
tures are key determinants of the level of postprandial
lipaemia, rather than the position of the fatty acid in tri-
acylglycerols [16].
Positive effects of β-palmitate in infants
The influence of the binding of palmitic acid at various
positions to a molecule of glycerol in fats has been in-
vestigated in animals and also in human studies, with
infants born prematurely or at term. The studies inves-
tigated the influence of a higher content of β-palmitate
on calcium metabolism, digestion and absorption of
fats, creation of bone matrix, consistency of stools and
other parameters. Regarding the availability of synthetic
β-palmitate, as well as formulas with its increased con-
tent, the evidence for a positive effect of this unique,
from human milk-derived fat is increasing (Table 1).
The impact of β-palmitate on calcium metabolism
Calcium is an essential mineral, especially at the time of
intensive growth and skeleton formation. The stools of
infants fed supplemental milk formula with a higher
content of β-palmitate have a comparable amount of
calcium and also fatty acids as those of fully breastfed
infants. This amount was distinctly lower, compare to
the infants fed a supplemental milk formula containing
little β-palmitate. From a practical point of view, it is
evident that β-palmitate in the supplemental milk for-
mula, similar to its function in human milk, positively
influences calcium metabolism by increasing its absorp-
tion from the intestinal lumen and positively influencing
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Table 1 Characteristics of studies investigating the influence of β-palmitate on infant’s health
Authors [Reference] Patients Duration
of the study





to standard formula (n = 18)
and modified formula (n = 20)
3 weeks RCT Significant tendency towards
softer stools in constipated
infants fed formula containing
sn-2 palmitic acid, mixture of
prebiotic oligosaccharides and
partially hydrolysed whey protein;
no difference in stool frequency.
Carnielli et al.,
1995 [18]
Preterm infants (n = 12) 1 week RCT A formula containing triglycerides
similar to human milk
(26 % palmitic acid, esterified
predominantly to the sn-2 position)
had significant effects on fatty acid
intestinal absorption, and improved




Healthy, term infants (n = 9) At least
5 weeks
RCT Dietary triacylglycerols containing
palmitic acid predominantly at the
β-position, as in human milk, had
significant beneficial effects on the
intestinal absorption of fat and calcium
in healthy term infants.
Innis et al., 1994 [2] Breastfed (n = 17) and formula-fed
infants (n = 18)
3 months Not specified 16:0 triacylglycerols were absorbed




Healthy, term neonates fed with standard
formula (n = 103), high sn-2 formula
(n = 100) and breastfed infants (n = 120)
12 weeks RCT Infants receiving high sn-2 formula,
similar to breastfed infants, had higher
bone mineral content, softer stools
and a lower proportion of stool soap




83 term infants fed with high
β-palmitate formula (n = 30),
standard formula (n = 28) and
breastfed (n = 25)
12 weeks RCT Infants consuming high β-palmitate
formula had changes in the bone
speed of sound that were comparable
to breastfed infants and favourable




Formula-fed infants with high
β-palmitate (n = 21), standard
vegetable oil mix (n = 21) or
breastfed infants (n = 21)
12 weeks RCT Consumption of a high β-palmitate
formula, comparable to breast-feeding,
affects infant crying patterns during the
first weeks of life.
Lopéz-Lopéz et al.,
2001 [3]
36 healthy full-term infants:
12 infants fed with human milk,
12 infants fed with formula containing
19 % palmitic acid esterified in the
β-position (α-formula) for 2 months,
12 infants fed with the α-formula
during the first month and with
the β-formula (44.5 % palmitic acid
in β-position) during the second month
2 months RCT of formula-fed infants,
non-randomised group of
breastfed infants
Consumption of a high β-palmitate
formula significantly reduced the contents
of total fatty acids and palmitic acid
in faeces.
Lopéz A. et al.,
2002 [36]
120 term infants with different formulas
(40 colostrum, 40 transitional milk,
40 mature milk, 11 infant formulas)
15 days RCT of formula-fed
infants, non-randomised
group of breastfed infants
Human milk in Spain had low saturated
fatty acids, high monounsaturated fatty
acids and high linolenic acid. Infant
formulas resemble the fatty acid profile
of human milk, but the distribution of




24 preterm infants fed with formula that
differed in content of palmitate in the
sn-2 position in the formula
(74, 8.4 and 28 %).
4 days RCT Use of a formula rich in sn-2 position
palmitate improved palmitate absorption,
reduced the formation of insoluble
calcium soaps in the stool, and improved
calcium absorption.
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mineralization of the growing skeleton [3]. In an animal
model, a β-palmitate-rich formula increased calcium ab-
sorption through the increase of its solubility in the
small intestinal content [17]. The high content of β-
palmitate in supplemental milk formula lowers the
amount of calcium in the stool and subsequently, there
is higher excretion in the urine [18]. There is a signifi-
cant direct relationship between the amount of β-
palmitate in supplemental milk formula and the grade of
calcium absorption, as well as a decrease in the creation
of calcium soaps and the increased grade of absorption
of fatty acids [13].
The impact of β-palmitate on the bone matrix
Early childhood is critical for the optimal development
of bone matrix mineralization and diet significantly in-
fluences this complex process [19]. As already men-
tioned, a higher content of β-palmitate has a positive
impact on calcium absorption. In a study with 100 infans
who were fed milk formula with 50 % proportion of β-
palmitate, the whole body mass of bone mineral was
compared and evaluated densitometrically against fully
breastfed infants and infants fed a standard milk formula
with a low content of β-palmitate. The formula with a
high β-palmitate content led to a significantly higher
Table 1 Characteristics of studies investigating the influence of β-palmitate on infant’s health (Continued)
Nelson and Innis,
1999 [15]
87 healthy, full-term infants
(40 breastfed, 22 fed with
the standard formula and
25 fed with the formula
containing synthesised
triacylglycerol (39 % of the
16:0 esterified at the
triacylglycerol 2 position).
120 days RCT of formula-fed infants,
non-randomised group of
breastfed infants
50 % of the dietary triacylglycerol
2-position 16:0 is conserved through
digestion, absorption and chylomicron
triacylglycerol synthesis in breastfed
and formula-fed Infants. Infants fed
the synthesised triacylglycerol formula
had significantly lower HDL-cholesterol
and apolipoprotein A-I and higher
apolipoprotein B concentrations than
infants fed the standard formula.
Nowacki et al.,
2014 [24]
165 healthy, term infants fed
with standard formula (n = 54),
formula containing high sn-2
palmitate (n = 56), or formula
containing high sn-2 palmitate
plus oligofructose (n = 55), and
55 breastfed infants
25–45 days RCT of formula-fed infants,
non-randomised group of
breastfed infants
Increasing sn-2 palmitate in infant
formula reduced stool palmitate soaps.
A combination of high sn-2 palmitate
and oligofructose reduced stool palmitate




20 formula-fed and 10
breastfed infants
7 days Single blinded trial Differences in lipids between formula-
and breastfed infants’ stools were due
almost entirely to FAs (mainly C16:0
and C18:0) excreted as soaps. FA soaps,
predominantly saturated, accounted for
one-third of the stool dry weight. These
data support the hypothesis that calcium




199 formula-fed infants with
infantile colic fed with standard
formula and simethicone (n = 103)
and special formula (partially
hydrolysed whey proteins, mixture
of oligosaccharides, low lactose
level and modified vegetable oil
with 41 % palmitic acid in the
β-position and starch, n = 96)
14 days RCT The use of special formula (containing
partially hydrolysed whey proteins,
prebiotic oligosaccharides with a high
β-palmitic acid content) reduced crying
episodes in infants with colic compared
with a standard formula and simethicone
Yao et al., 2014 [26] 300 healthy, formula-fed, term infants,
fed with four formulas: standard formula
(n = 75), high sn-2 palmitate term infant
formula (n = 74), an identical formula
supplemented with oligofructose at two
concentrations (3 vs. 5 g) (n = 76, n = 75),
and breastfed infants (n = 73)
8 weeks RCT High sn-2-palmitate formulas led to
reduced stool soaps, softer stools and
increased bifidobacteria, whereas addition




36 term infants: 14 breastfed,
22 formula-fed who were randomly
assigned into high β-palmitate
(n = 14) or low β-palmitate (n = 8)
formula-fed infants
6 week RCT High β-palmitate formula beneficially
affected infant gut microbiota by
increasing the Lactobacillus and
bifidobacteria counts in faecal stools.
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mass of bone mineral in comparison with the group fed
the control standard formula. In contrast, there was no
difference between the group with β-palmitate and the
fully breastfed infants [20]. A recent double-blind con-
trolled study analysed the impact of supplemental nutrition
with various contents of β-palmitate on anthropometric
parameters and bone mass in a group of infants born at
term. Quantitative ultrasound measurements of bone
speed of sound (SOS) are an important tool for the diagno-
sis and follow-up of bone strength in infants. SOS is
directly proportional to the quality, strength and density of
the bone matrix. The results showed that breastfed in-
fants and infants fed a formula with a high content of
β-palmitate had a significantly higher bone speed of
sound compared to infants fed a standard milk formula
with a low content of β-palmitate [21]. However, fur-
ther studies are needed to confirm this effect and to
analyse the effect of β-palmitate supplementation in
supplemental milk nutrition on bone matrix in the
long term.
Influence of β-palmitate on the absorption of fatty acids
and stool consistency
Increased absorption of palmitate at its binding in sn-2
position to the glycerol skeleton could present an import-
ant source of energy for a child. Increasing β-palmitate
content leads to a positive influence of the resorption of
fatty acids, as well as their spectrum in plasma being more
similar to observations in fully breastfed infants [2, 22].
The formation of insoluble calcium soaps is responsible for
a harder stool [23]. In addition, calcium in this form is un-
available for a child and it is excreted from the body in the
stool. Breastfed infants have a softer stool in comparison
with infants fed standard formulas with a small amount of
β-palmitate [11, 20, 24]. With increasing β-palmitate con-
tent, due to better absorption of fatty acids and a higher
proportion of absorbable 2-monoacylglycerols, the risk of
formation of insoluble calcium soaps decreases with subse-
quent improvement in the stool consistency, which was
softer without an increase in the overall stool volume [20].
In a small double-blind randomised cross-over trial in term
infants with constipation, a new formula containing a high
concentration of β-palmitate, as well as a mixture of pre-
biotic oligosaccharides and partially hydrolysed whey pro-
tein, resulted in a strong tendency towards a softer stool in
constipated infants, but no difference in defecation fre-
quency. Therefore, this formula may be recommended for
constipated infants [25]. A limitation of this study is a lot
of variables influencing stool consistence. Recent double-
blind studies in healthy term infants indicate that high β-
palmitate formula led to reduced stool soap formation and
softer stools, and this effect was more visible with the
addition of prebiotic oligofructose [24, 26].
It might be said that the high content of β-palmitate
in supplemental milk formula positively influences me-
tabolism of fatty acids and their absorption from the
intestinal lumen with a subsequent energetic improve-
ment and mineral balance. Newborns and infants in the
first few weeks of life still have some immaturity of the
pancreatic lipase system and therefore, adding β-palmitate
to the supplemental milk formula by-passes this transient
physiological insufficiency by providing sufficient absorp-
tion of fatty acids, as well as calcium. Similar results with
improvements in absorption of fatty acids, lowering of
calcium waste in the stool due to its increased resorption,
and subsequent softening of the stool has been observed
by other authors [11, 24, 27]. Several studies have shown
that palmitic acid can be efficiently absorbed, thus
avoiding fatty soap formation if it is present in the sn-2
position [28]. Observations that an increased content
of β-palmitate leads to lower absorption of essential
polyunsaturated fatty acids have not been confirmed
subsequently The formula with a higher content of β-
palmitate was well tolerated and had no negative im-
pacts on growth [20, 22].
Impact of β-palmitate on the duration of crying and
on sleep
In a randomised controlled study the use of a partially
hydrolysed whey proteins formula supplemented with
prebiotic oligosaccharides and with a high β-palmitic
acid content induces a reduction of crying episodes in
infants with colic compared with a standard formula and
simethicone. Regarding the fact that the control formula,
besides β-palmitate, also lacked oligosaccharides and
whey hydrolysate, this observed clinical effect might be
partially attributed to these other components [29]. In a
double-blind randomized clinical trial a significant re-
duction of crying duration was observed in the group of
infants fed a formula with a high content of β-palmitate
in comparison with infants fed a control low-β-palmitate
formula. There was no significant difference in crying
pattern between breastfed infants and infants fed a for-
mula with a high content of β-palmitate [30]. In another
study with formulas supplemented with high β-palmitate
content, a significantly lower number of crying infants,
as well as shorter duration of crying episodes during the
day and night, was observed. The reduction of crying
was observed especially during the evening and night,
which effect might be explained by a complex mechanism
of β-palmitate activity, namely establishment of circadian
biorhythms of a child and with a positive influence on the
system of neuroendocrine mediators and regulators [13].
There may also have been an effect due to the softening of
stools and thus a decrease in the gastrointestinal discom-
fort in relation to solid stool.
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The impact of β-palmitate on intestinal microflora
An important component of the intestine is the intes-
tinal microbiome (microflora), which is an important
“organ” with many functions not only at the level of the
intestine, but also at the level of the whole organism, e.g.
modulation of the inflammatory and immune response,
prevention of colonisation by invasive pathogens, creation
of essential compounds for the organism (e.g. vitamins,
short-chain fatty acids), participation in the digestion of
some nutrients, as well as regulation of intestinal matur-
ation of the intestine and proliferation of intestinal epithe-
lial cells [13]. After birth, the child has a sterile intestinal
lumen, which is rapidly colonised by particular microor-
ganisms, and the character of the intestinal microbiome
may have important consequences regarding the pre-
vention or origination of some pathological diseases,
including gastrointestinal diseases, as well as extraintes-
tinal diseases (e.g. allergic diseases, neuropsychiatric
diseases and inflammatory intestinal diseases) [31–33].
An important factor modulating the creation of the in-
testinal microbiome is the nutrition of the child, and
from this point of view, we consider human milk as an
ideal creator and regulator of the physiological intes-
tinal microbiome. In a recent clinical study, a positive
influence of a high content of β-palmitate in supple-
mental milk formula was found as it led to an increase
in Lactobacillus and bifidobacteria with subsequent
correct intestinal maturation with antagonism of patho-
genic bacteria and positive immunomodulatory effects
[34]. The most recent double-blind study in 300 healthy
term infants also showed that a high content of β-
palmitate in formula resulted in higher faecal bifidobac-
teria concentration and improved stool consistency,
and that there was no difference compared with human
milk-fed infants [26]. These studies also showed an
immunomodulatory effect of β-palmitate via a positive
influence of the intestinal microbiome. Further studies
are needed.
The influence of β-palmitate on inflammatory processes
in the intestine
Interesting results were shown by an experimental study
using an animal model in which the possible protective
effect of β-palmitate on the development of intestinal in-
flammation was studied. As a model, a mouse deficient
in the creation of mucin-2, which presents an important
physiological protective barrier to the intestinal mucosa
with anti-inflammatory effects, was used. In the group of
deficient mice that were fed a formula with a high con-
tent of β-palmitate, a lower grade of intestinal erosion
was observed, as well as other morphological changes in
comparison with the group fed a formula containing
plant oil with a low content of β-palmitate. The respon-
sible mechanism could be represented by the activation
Fig. 1 Possible beneficial effects of β-palmitic acid on children’s health
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of expression of antioxidant enzymes (superoxide dis-
mutase, glutathione peroxidase) and the stimulation of
T-regulatory lymphocytes (increased expression of tran-
scription factor Foxp3), together with an increase in
gene expression for PPAR-γ (peroxisome proliferator-
activated receptors) and for cytokine TGF-β, which have
important functions in the homoeostasis of the intestinal
mucosa and regulation of the inflammatory response to
various stimuli [35]. These recent observations open
new views and perspectives on the use of β-palmitate in
supplemental milk formulas. The anti-inflammatory poten-
tial of β-palmitate needs further investigation in humans.
Conclusions
The composition and functions of maternal milk are
unique and they are the basis for the development of
modern supplemental milk formulas, providing the most
adequate substitution for infants who cannot be, for
various reasons, breastfed human milk. Besides particu-
lar immunomodulatory factors, the research is focused
on the uniqueness of the fat composition of human milk
with a high content of β-palmitate. On the basis of avail-
able studies, we know about several positive biologic ef-
fects of β-palmitate being added to supplemental milk
formulas according to the pattern of human milk (Fig. 1).
Further studies are necessary to prove these observations
and, at the same time, elucidate other physiological posi-
tive effects of β-palmitate on neonate development, not
only in the short term, but also in the long term.
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